| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 5.260.390.750 $ | 99,89 | 196.001.475 | |||||||
| KRYSTAL BIOTECH INC | KRYSTAL BIOTECH INC | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 557.064.277 $ | 10,58 | 1.802.622 | |
| ABBVIE INC | ABBVIE INC | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 485.555.443 $ | 9,22 | 2.230.183 | |
| AMGEN INC | AMGEN INC | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 343.856.191 $ | 6,53 | 1.020.981 | |
| GILEAD SCIENCES INC | GILEAD SCIENCES INC | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 253.575.040 $ | 4,82 | 1.886.298 | |
| ALNYLAM PHARMACEUTICALS INC | ALNYLAM PHARMACEUTICALS INC | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 154.518.032 $ | 2,93 | 511.683 | |
| PRAXIS PRECISION MEDICINES INC. | PRAXIS PRECISION MEDICINES INC | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 129.989.007 $ | 2,47 | 371.429 | |
| INSMED INC | INSMED INC | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 118.584.679 $ | 2,25 | 1.109.201 | |
| ARGENX SE | ARGENX SE SPONSORED ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 118.245.770 $ | 2,25 | 141.444 | |
| ASCENDIS PHARMA A/S | ASCENDIS PHARMA AS | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 107.662.668 $ | 2,04 | 480.401 | |
| REVOLUTION MEDICINES INC | REVOLUTION MEDICINES INC | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 106.310.339 $ | 2,02 | 675.072 | |
| UCB SA | UCB SA | EC | BE0003739530 | Long | Börsenkurs (Stufe 1) | 105.065.680 $ | 2,00 | 357.874 | |
| JAZZ PHARMACEUTICALS PLC | JAZZ PHARMA PLC | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 97.067.793 $ | 1,84 | 410.452 | |
| SCHOLAR ROCK HOLDING CORP | SCHOLAR ROCK HOLDING CORP | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 81.367.136 $ | 1,55 | 1.650.449 | |
| NATERA INC | NATERA INC | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 74.054.303 $ | 1,41 | 331.532 | |
| MODERNA INC | MODERNA INC | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 67.601.044 $ | 1,28 | 1.432.529 | |
| AXSOME THERAPEUTICS INC | AXSOME THERAPEUTICS INC | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 67.197.278 $ | 1,28 | 286.580 | |
| BIOGEN INC | BIOGEN INC | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 66.411.660 $ | 1,26 | 338.835 | |
| PROTAGONIST THERAPEUTICS INC | PROTAGONIST THERAPEUTICS INC | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 60.503.906 $ | 1,15 | 607.713 | |
| ROIVANT SCIENCES LTD | ROIVANT SCIENCES LTD | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 59.452.746 $ | 1,13 | 1.982.419 | |
| COGENT BIOSCIENCES INC | COGENT BIOSCIENCES INC | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 56.103.598 $ | 1,07 | 1.604.794 | |
| TANGO THERAPEUTICS INC | TANGO THERAPEUTICS INC | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 51.419.177 $ | 0,98 | 2.339.362 | |
| CELCUITY INC | CELCUITY INC | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 49.909.728 $ | 0,95 | 375.600 | |
| MADRIGAL PHARMACEUTICALS INC | MADRIGAL PHARMACEUTICALS INC | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 48.779.701 $ | 0,93 | 98.095 | |
| BRIDGEBIO PHARMA INC | BRIDGEBIO PHARMA INC | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 46.865.963 $ | 0,89 | 707.304 | |
| IMMUNOME INC | IMMUNOME INC | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 46.534.225 $ | 0,88 | 2.131.664 | |
| UNITED THERAPEUTICS CORP DEL | UNITED THERAPEUTICS CORP DEL | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 45.988.321 $ | 0,87 | 82.591 | |
| KYMERA THERAPEUTICS INC | KYMERA THERAPEUTICS INC | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 45.305.426 $ | 0,86 | 556.441 | |
| ARRIVENT BIOPHARMA INC | ARRIVENT BIOPHARMA INC | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 43.582.837 $ | 0,83 | 1.439.803 | |
| CANDEL THERAPEUTICS INC | CANDEL THERAPEUTICS INC | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 40.377.450 $ | 0,77 | 4.864.753 | |
| STOKE THERAPEUTICS INC | STOKE THERAPEUTICS INC | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 39.988.082 $ | 0,76 | 1.293.694 | |
| DIANTHUS THERAPEUTICS INC | DIANTHUS THERAPEUTICS INC | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 39.112.379 $ | 0,74 | 420.518 | |
| TRAVERE THERAPEUTICS INC | TRAVERE THERAPEUTICS INC | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 37.689.413 $ | 0,72 | 798.843 | |
| IONIS PHARMACEUTICALS INC | IONIS PHARMACEUTICALS INC | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 36.442.841 $ | 0,69 | 476.377 | |
| DYNE THERAPEUTICS INC | DYNE THERAPEUTICS INC | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 36.408.906 $ | 0,69 | 1.883.544 | |
| GALDERMA GROUP AG | GALDERMA GROUP AG | EC | CH1335392721 | Long | Modellwert (Stufe 2) | 35.728.924 $ | 0,68 | 168.890 | |
| CORCEPT THERAPEUTICS INC | CORCEPT THERAPEUTICS INC | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 35.213.780 $ | 0,67 | 506.746 | |
| CYTOKINETICS INC | CYTOKINETICS INC | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 34.478.673 $ | 0,65 | 449.175 | |
| ABIVAX SA | ABIVAX SA | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 33.860.439 $ | 0,64 | 255.300 | |
| TREVI THERAPEUTICS INC | TREVI THERAPEUTICS INC | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 33.579.460 $ | 0,64 | 2.374.785 | |
| ORUKA THERAPEUTICS INC | ORUKA THERAPEUTICS INC | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 32.933.836 $ | 0,63 | 562.683 | |
| APOGEE THERAPEUTICS INC | APOGEE THERAPEUTICS INC | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 32.745.686 $ | 0,62 | 398.657 | |
| ERASCA INC | ERASCA INC | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 32.532.451 $ | 0,62 | 2.533.680 | |
| ARROWHEAD PHARMACEUTICALS INC | ARROWHEAD PHARMACEUTICALS INC | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 31.894.640 $ | 0,61 | 409.378 | |
| DISC MEDICINE INC | DISC MEDICINE INC | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 31.638.627 $ | 0,60 | 454.774 | |
| CRINETICS PHARMACEUTICALS INC | CRINETICS PHARMACEUTICALS INC | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 31.528.264 $ | 0,60 | 886.871 | |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | EC | GB00BRXB0C07 | Long | Börsenkurs (Stufe 1) | 30.847.088 $ | 0,59 | 637.600 | |
| NUVALENT INC | NUVALENT INC-A | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 30.180.516 $ | 0,57 | 273.399 | |
| SPYRE THERAPEUTICS INC | SPYRE THERAPEUTICS INC | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 29.631.746 $ | 0,56 | 403.153 | |
| ANNEXON INC | ANNEXON INC | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 27.546.044 $ | 0,52 | 5.082.296 | |
| INTELLIA THERAPEUTICS INC | INTELLIA THERAPEUTICS INC | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 26.941.700 $ | 0,51 | 1.914.833 | |
| VAXCYTE INC | VAXCYTE INC | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 24.402.407 $ | 0,46 | 474.755 | |
| EDGEWISE THERAPEUTICS INC | EDGEWISE THERAPEUTICS INC | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 23.892.358 $ | 0,45 | 699.425 | |
| VIRIDIAN THERAPEUTICS INC | VIRIDIAN THERAPEUTICS INC | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 23.052.316 $ | 0,44 | 1.308.304 | |
| ARCUS BIOSCIENCES INC | ARCUS BIOSCIENCES INC | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 21.607.418 $ | 0,41 | 852.700 | |
| BIO AB HOLDINGS LLC | BIO AB2 HOLDINGS LLC ARC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 30.080.155 $ | 0,57 | 3.909.052 | |
| STRUCTURE THERAPEUTICS INC | STRUCTURE THERAPEUTICS INC ADR | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 21.323.775 $ | 0,40 | 542.038 | |
| VIATRIS INC | VIATRIS INC | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 20.978.099 $ | 0,40 | 1.290.166 | |
| ALLOGENE THERAPEUTICS INC | ALLOGENE THERAPEUTICS INC | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 20.716.758 $ | 0,39 | 9.546.893 | |
| BICARA THERAPEUTICS INC | BICARA THERAPEUTICS INC | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 20.551.575 $ | 0,39 | 944.900 | |
| MAZE THERAPEUTICS INC | MAZE THERAPEUTICS INC | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 19.571.404 $ | 0,37 | 739.660 | |
| ZEALAND PHARMA A/S | ZEALAND PHARMA A/S | EC | DK0060257814 | Long | Börsenkurs (Stufe 1) | 19.165.690 $ | 0,36 | 377.990 | |
| SOLID BIOSCIENCES INC | SOLID BIOSCIENCES INC | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 19.133.758 $ | 0,36 | 2.606.779 | |
| XENON PHARMACEUTICALS INC | XENON PHARMACEUTICALS INC | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 18.912.718 $ | 0,36 | 345.564 | |
| IDEAYA BIOSCIENCES INC | IDEAYA BIOSCIENCES | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 18.800.593 $ | 0,36 | 637.957 | |
| SUMMIT THERAPEUTICS INC | SUMMIT THERAPEUTICS INC | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 18.726.914 $ | 0,36 | 1.067.669 | |
| VOR BIOPHARMA INC | VOR BIOPHARMA INC | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 17.750.303 $ | 0,34 | 1.185.725 | |
| NEWAMSTERDAM PHARMA COMPANY NV | NEWAMSTERDAM PHARMA COMPANY NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 17.638.216 $ | 0,33 | 523.700 | |
| MIRUM PHARMACEUTICALS INC | MIRUM PHARMACEUTICALS INC | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 17.315.900 $ | 0,33 | 170.600 | |
| RAPPORT THERAPEUTICS INC | RAPPORT THERAPEUTICS INC | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 16.916.784 $ | 0,32 | 428.273 | |
| TWIST BIOSCIENCE CORP | TWIST BIOSCIENCE CORP | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 15.970.228 $ | 0,30 | 238.825 | |
| BIOHAVEN LTD | BIOHAVEN LTD | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 15.952.345 $ | 0,30 | 1.448.896 | |
| AMYLYX PHARMACEUTICALS INC | AMYLYX PHARMACEUTICALS INC | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 15.744.461 $ | 0,30 | 1.097.175 | |
| MANNKIND CORP | MANNKIND CORP | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 15.375.572 $ | 0,29 | 4.078.401 | |
| KAILERA THERAPEUTICS INC | KAILERA THERAPEUTICS INC | EC | 482931102 | Long | Börsenkurs (Stufe 1) | 14.209.013 $ | 0,27 | 619.399 | |
| RELAY THERAPEUTICS INC | RELAY THERAPEUTICS INC | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 14.197.061 $ | 0,27 | 1.010.467 | |
| UNIQURE N.V. | UNIQURE N.V. | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 13.497.029 $ | 0,26 | 473.082 | |
| ENLIVEN THERAPEUTICS INC | ENLIVEN THERAPEUTICS INC | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 13.456.451 $ | 0,26 | 340.067 | |
| ALUMIS INC | ALUMIS INC | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 13.392.000 $ | 0,25 | 620.000 | |
| VIKING THERAPEUTICS INC | VIKING THERAPEUTICS INC | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 13.235.374 $ | 0,25 | 404.257 | |
| REPLIMUNE GROUP INC | REPLIMUNE GROUP INC | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 13.163.134 $ | 0,25 | 1.514.745 | |
| TECTONIC THERAPEUTIC INC | TECTONIC THERAPEUTIC INC | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 12.633.948 $ | 0,24 | 405.389 | |
| IDORSIA LTD | IDORSIA LTD | EC | CH0363463438 | Long | Börsenkurs (Stufe 1) | 12.440.392 $ | 0,24 | 2.174.283 | |
| MINERALYS THERAPEUTICS INC | MINERALYS THERAPEUTICS INC | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 12.155.850 $ | 0,23 | 385.900 | |
| PTC THERAPEUTICS INC | PTC THERAPEUTICS INC | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 11.846.352 $ | 0,22 | 160.411 | |
| DAMORA THERAPEUTICS INC | DAMORA THERAPEUTICS INC | EC | 36322Q206 | Long | Börsenkurs (Stufe 1) | 11.309.428 $ | 0,21 | 454.559 | |
| TYRA BIOSCIENCES INC | TYRA BIOSCIENCES INC | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 11.259.170 $ | 0,21 | 337.000 | |
| HEMAB THERAPEUTICS HOLDINGS INC | HEMAB THERAPEUTICS HOLDINGS INC | EC | 423494103 | Long | Börsenkurs (Stufe 1) | 10.815.066 $ | 0,21 | 379.476 | |
| FORTE BIOSCIENCES INC | FORTE BIOSCIENCES INC | EC | 34962G208 | Long | Börsenkurs (Stufe 1) | 10.747.680 $ | 0,20 | 563.591 | |
| EIKON THERAPEUTICS INC | EIKON THERAPEUTICS INC | EC | 282564103 | Long | Börsenkurs (Stufe 1) | 10.561.770 $ | 0,20 | 974.333 | |
| ABSCI CORP | ABSCI CORP | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 10.400.373 $ | 0,20 | 1.540.796 | |
| CAPRICOR THERAPEUTICS INC | CAPRICOR THERAPEUTICS INC | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 10.012.632 $ | 0,19 | 334.200 | |
| CITY THERAPEUTICS INC | CITY THERAPEUTICS INC SER B PC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 10.004.466 $ | 0,19 | 684.300 | |
| CYTOMX THERAPEUTICS INC | CYTOMX THERAPEUTICS INC | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 9.987.624 $ | 0,19 | 2.774.340 | |
| GUBRA A/S | GUBRA A/S | EC | DK0062266474 | Long | Börsenkurs (Stufe 1) | 9.258.962 $ | 0,18 | 166.002 | |
| IMMUNOVANT INC | IMMUNOVANT INC | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 9.064.959 $ | 0,17 | 272.221 | |
| RHYTHM PHARMACEUTICALS INC | RHYTHM PHARMACEUTICALS INC | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 8.814.601 $ | 0,17 | 99.803 | |
| TRIVENI BIO INC | TRIVENI BIO INC SERIES B PC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 11.744.265 $ | 0,22 | 9.555.965 | |
| VTV THERAPEUTICS INC | VTV THERAPEUTICS INC CL A | EC | 918385204 | Long | Börsenkurs (Stufe 1) | 8.684.040 $ | 0,16 | 260.391 | |
| BEONE MEDICINES LTD | BEONE MEDICINES LTD ADR | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 8.550.648 $ | 0,16 | 29.698 | |
| NUVATION BIO INC | NUVATION BIO INC | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 8.405.788 $ | 0,16 | 1.758.533 | |
| HANSA BIOPHARMA AB | HANSA BIOPHARMA AB | EC | SE0002148817 | Long | Börsenkurs (Stufe 1) | 8.358.579 $ | 0,16 | 2.290.077 | |
| IMMUNOCORE HOLDINGS PLC | IMMUNOCORE HOLDINGS LTD ADR | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 8.297.208 $ | 0,16 | 287.200 | |
| OLEMA PHARMACEUTICALS INC | OLEMA PHARMACEUTICALS INC | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 8.284.639 $ | 0,16 | 628.100 | |
| BEAM THERAPEUTICS INC | BEAM THERAPEUTICS INC | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 8.065.018 $ | 0,15 | 244.914 | |
| CG ONCOLOGY INC | CG ONCOLOGY INC | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 8.018.467 $ | 0,15 | 128.728 | |
| SENSORION SA | SENSORION SA | EC | FR0012596468 | Long | Börsenkurs (Stufe 1) | 8.013.196 $ | 0,15 | 17.132.230 | |
| OCULAR THERAPEUTIX INC | OCULAR THERAPEUTIX INC | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 7.063.840 $ | 0,13 | 784.000 | |
| ZENAS BIOPHARMA INC | ZENAS BIOPHARMA INC | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 11.841.081 $ | 0,22 | 643.537 | |
| GERON CORP | GERON CORP | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 6.815.265 $ | 0,13 | 5.452.212 | |
| JADE BIOSCIENCES INC | JADE BIOSCIENCES INC | EC | 008064206 | Long | Börsenkurs (Stufe 1) | 6.768.715 $ | 0,13 | 321.707 | |
| IMMUNEERING CORP | IMMUNEERING CORP | EC | 45254E107 | Long | Börsenkurs (Stufe 1) | 6.322.754 $ | 0,12 | 1.095.798 | |
| BIONTECH SE | BIONTECH SE ADR | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 6.227.155 $ | 0,12 | 64.900 | |
| CANDID THERAPEUTICS | CANDID THERAPEUTICS INC SER B PC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 6.183.335 $ | 0,12 | 1.666.667 | |
| X4 PHARMACEUTICALS INC | X4 PHARMACEUTICALS INC | EC | 98420X202 | Long | Börsenkurs (Stufe 1) | 6.156.835 $ | 0,12 | 1.428.500 | |
| NURIX THERAPEUTICS INC | NURIX THERAPEUTICS INC | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 5.920.225 $ | 0,11 | 333.346 | |
| AKTIS ONCOLOGY INC | AKTIS ONCOLOGY INC | EC | 01021M104 | Long | Börsenkurs (Stufe 1) | 5.876.783 $ | 0,11 | 283.355 | |
| CAMP4 THERAPEUTICS CORP | CAMP4 THERAPEUTICS CORP | EC | 13463J101 | Long | Börsenkurs (Stufe 1) | 11.206.853 $ | 0,21 | 2.552.814 | |
| ODYSSEY THERAPEUTICS INC | ODYSSEY THERAPEUTICS | EC | 67613T104 | Long | Börsenkurs (Stufe 1) | 5.774.895 $ | 0,11 | 339.500 | |
| CARDURION PHARMACEUTICALS INC | CARDURION PHARMACEUTICALS INC SER B PC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 5.635.412 $ | 0,11 | 1.020.908 | |
| DESIGN THERAPEUTICS INC | DESIGN THERAPEUTICS INC | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 5.606.077 $ | 0,11 | 534.931 | |
| TG THERAPEUTICS INC | TG THERAPEUTICS INC | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 5.548.004 $ | 0,11 | 146.231 | |
| TAYSHA GENE THERAPIES INC | TAYSHA GENE THERAPIES INC | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 5.520.594 $ | 0,10 | 940.476 | |
| LB PHARMACEUTICALS INC | LB PHARMACEUTICALS INC | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 5.250.836 $ | 0,10 | 187.731 | |
| PROTHENA CORP PLC | PROTHENA CORP PLC | EC | IE00B91XRN20 | Long | Börsenkurs (Stufe 1) | 5.044.363 $ | 0,10 | 495.517 | |
| NEURONA THERAPEUTICS INC | NEURONA THERAPEUTICS INC SER F PC PERP PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 4.741.033 $ | 0,09 | 1.618.100 | |
| PHARVARIS BV | PHARVARIS BV | EC | NL00150005Y4 | Long | Börsenkurs (Stufe 1) | 4.461.086 $ | 0,08 | 147.914 | |
| DENALI THERAPEUTICS INC | DENALI THERAPEUTICS INC | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 4.318.734 $ | 0,08 | 205.263 | |
| SCORPION THERAPEUTICS INC | SCORPION THERAPEUTICS INC CVR 03/05/2040 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 4.288.204 $ | 0,08 | 10.332.896 | |
| SANA BIOTECHNOLOGY INC | SANA BIOTECHNOLOGY INC | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 4.168.402 $ | 0,08 | 1.263.152 | |
| VERA THERAPEUTICS INC | VERA THERAPEUTICS INC | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 3.872.142 $ | 0,07 | 109.013 | |
| SIONNA THERAPEUTICS INC | SIONNA THERAPEUTICS INC | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 3.464.138 $ | 0,07 | 80.900 | |
| PARABILIS MEDICINES INC | PARABILIS MEDICINES INC SER F PC PP | EP | Long | Modellwert (Stufe 2) | beschränkt | 3.382.208 $ | 0,06 | 491.600 | |
| CRESCENT BIOPHARMA INC | CRESCENT BIOPHARMA INC PIPE | EC | Long | Börsenkurs (Stufe 1) | beschränkt | 5.421.926 $ | 0,10 | 262.563 | |
| ARS PHARMACEUTICALS INC | ARS PHARMACEUTICALS INC | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 3.039.865 $ | 0,06 | 335.156 | |
| JANUX THERAPEUTICS INC | JANUX THERAPEUTICS INC | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 3.015.315 $ | 0,06 | 206.670 | |
| ALECTOR INC | ALECTOR INC | EC | 014442107 | Long | Börsenkurs (Stufe 1) | 2.981.241 $ | 0,06 | 1.380.204 | |
| CARTESIAN THERAPEUTICS INC | CARTESIAN THERAPEUTICS INC | EC | 816212302 | Long | Börsenkurs (Stufe 1) | 4.325.678 $ | 0,08 | 5.752.282 | |
| MOONLAKE IMMUNOTHERAPEUTICS | MOONLAKE IMMUNOTHERAPEUTICS | EC | 61559X104 | Long | Börsenkurs (Stufe 1) | 2.753.442 $ | 0,05 | 143.558 | |
| NATIONAL RESILIENCE INC | NATIONAL RESILIENCE INC SER B PC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 2.481.697 $ | 0,05 | 732.064 | |
| SHATTUCK LABS INC | SHATTUCK LABS INC | EC | 82024L103 | Long | Börsenkurs (Stufe 1) | 2.330.389 $ | 0,04 | 391.662 | |
| MBX BIOSCIENCES INC | MBX BIOSCIENCES INC | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 2.300.457 $ | 0,04 | 73.100 | |
| VERTEX PHARMACEUTICALS INC | VERTEX PHARMACEUTICALS INC | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 2.285.139 $ | 0,04 | 5.106 | |
| WAVE LIFE SCIENCES LTD | WAVE LIFE SCIENCES LTD | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 2.269.705 $ | 0,04 | 344.940 | |
| GH RESEARCH PLC | GH RESEARCH PLC | EC | IE000GID8VI0 | Long | Börsenkurs (Stufe 1) | 2.219.075 $ | 0,04 | 92.500 | |
| ZURA BIO LTD | ZURA BIO LTD A | EC | KYG9TY5A1016 | Long | Börsenkurs (Stufe 1) | 2.191.525 $ | 0,04 | 509.657 | |
| BRIDGEBIO ONCOLOGY THERAPEUTIC | BRIDGEBIO ONCOLOGY THERAPEUTIC | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 2.155.491 $ | 0,04 | 240.300 | |
| VERADERMICS INC | VERADERMICS INC | EC | 922967104 | Long | Börsenkurs (Stufe 1) | 2.098.928 $ | 0,04 | 20.800 | |
| KARDIGAN INC | KARDIGAN, INC SER B PC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 1.996.723 $ | 0,04 | 93.611 | |
| CELLCENTRIC LTD | CELLCENTRIC LTD SER D PC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 1.989.572 $ | 0,04 | 417.101 | |
| PALVELLA THERAPEUTICS INC | PALVELLA THERAPEUTICS INC | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 1.978.282 $ | 0,04 | 16.700 | |
| UPSTREAM BIO INC | UPSTREAM BIO INC | EC | 91678A107 | Long | Börsenkurs (Stufe 1) | 1.961.733 $ | 0,04 | 234.657 | |
| FOGHORN THERAPEUTICS INC | FOGHORN THERAPEUTICS INC | EC | 344174107 | Long | Börsenkurs (Stufe 1) | 1.582.170 $ | 0,03 | 1.096.736 | |
| NEUROGENE INC | NEUROGENE INC | EC | 64135M105 | Long | Börsenkurs (Stufe 1) | 1.448.174 $ | 0,03 | 51.100 | |
| ATEA PHARMACEUTICALS INC | ATEA PHARMACEUTICALS INC | EC | 04683R106 | Long | Börsenkurs (Stufe 1) | 1.343.382 $ | 0,03 | 287.662 | |
| ANAPTYSBIO INC | ANAPTYSBIO INC | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 1.297.111 $ | 0,02 | 23.300 | |
| ZYMEWORKS DELAWARE INC | ZYMEWORKS DELAWARE INC | EC | 98985Y108 | Long | Börsenkurs (Stufe 1) | 1.203.048 $ | 0,02 | 47.873 | |
| LEXICON PHARMACEUTICALS INC | LEXICON PHARMACEUTICALS INC | EC | 528872302 | Long | Börsenkurs (Stufe 1) | 1.123.354 $ | 0,02 | 515.300 | |
| PERSPECTIVE THERAPEUTICS INC | PERSPECTIVE THERAPEUTICS INC | EC | 46489V302 | Long | Börsenkurs (Stufe 1) | 1.018.884 $ | 0,02 | 258.600 | |
| TUBULIS GMBH | TUBULIS GMBH CVR (MILESTONE 2) 05/21/2036 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.358.092 $ | 0,06 | 119.600 | |
| ATYR PHARMA INC | ATYR PHARMA INC | EC | 002120202 | Long | Börsenkurs (Stufe 1) | 951.867 $ | 0,02 | 1.754.594 | |
| LEGEND BIOTECH CORP | LEGEND BIOTECH CORP SPON ADR | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 888.404 $ | 0,02 | 32.710 | |
| TARSUS PHARMACEUTICALS INC | TARSUS PHARMACEUTICALS INC | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 683.100 $ | 0,01 | 11.500 | |
| CYCLERION THERAPEUTICS INC | KORSANA BIOSCIENCES FWD CMMT PIPE | EC | Long | Schätzwert (Stufe 3) | beschränkt | 644.526 $ | 0,01 | 251.640 | |
| BIOMEA FUSION INC | BIOMEA FUSION INC | EC | 09077A106 | Long | Börsenkurs (Stufe 1) | 625.532 $ | 0,01 | 498.797 | |
| REGENERON PHARMACEUTICALS INC | REGENERON PHARMACEUTICALS INC | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 614.780 $ | 0,01 | 1.000 | |
| SEPTERNA INC | SEPTERNA INC | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 585.880 $ | 0,01 | 19.400 | |
| HARMONY BIOSCIENCES HOLDINGS INC | HARMONY BIOSCIENCES HOLDINGS INC | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 553.615 $ | 0,01 | 17.525 | |
| BELITE BIO INC | BELITE BIO INC ADR | EC | 07782B104 | Long | Börsenkurs (Stufe 1) | 446.958 $ | 0,01 | 3.100 | |
| INMED PHARMACEUTICALS INC | MENTARI THERAPEUTICS FWD CMMT PIPE | EC | Long | Schätzwert (Stufe 3) | beschränkt | 441.672 $ | 0,01 | 191.200 | |
| KORRO BIO INC | KORRO BIO INC PIPE | EC | Long | Börsenkurs (Stufe 1) | beschränkt | 440.733 $ | 0,01 | 32.866 | |
| AVALYN PHARMA INC | AVALYN PHARMA INC | EC | 05348Y105 | Long | Börsenkurs (Stufe 1) | 431.700 $ | 0,01 | 15.000 | |
| ELEVATEBIO, LLC | ELEVATEBIO LLC SER C PC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 398.544 $ | 0,01 | 216.600 | |
| FIRST TRACKS BIOTHERAPEUTICS INC | FIRST TRACKS BIOTHERAPEUTICS INC | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 371.868 $ | 0,01 | 23.300 | |
| BIOCRYST PHARMACEUTICALS INC | BIOCRYST PHARMACEUTICALS INC | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 337.520 $ | 0,01 | 37.881 | |
| ANTARES THERAPEUTICS INC | ANTARES THERAPEUTICS INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 296.205 $ | 0,01 | 325.500 | |
| LENZ THERAPEUTICS INC | LENZ THERAPEUTICS INC | EC | 52635N103 | Long | Börsenkurs (Stufe 1) | 296.091 $ | 0,01 | 38.058 | |
| GENERATE BIOMEDICINE INC | GENERATE BIOMEDICINE INC | EC | 370920100 | Long | Börsenkurs (Stufe 1) | 286.016 $ | 0,01 | 21.800 | |
| KEROS THERAPEUTICS INC | KEROS THERAPEUTICS | EC | 492327101 | Long | Börsenkurs (Stufe 1) | 276.503 $ | 0,01 | 24.578 | |
| SEAPORT THERAPEUTICS INC | SEAPORT THERAPEUTICS INC | EC | 81221K108 | Long | Börsenkurs (Stufe 1) | 231.013 $ | 0,00 | 12.700 | |
| NOVOCURE LTD | NOVOCURE LTD | EC | JE00BYSS4X48 | Long | Börsenkurs (Stufe 1) | 189.366 $ | 0,00 | 11.113 | |
| BIOXCEL THERAPEUTICS INC | BIOXCEL THERAPEUTICS INC | EC | 09075P204 | Long | Börsenkurs (Stufe 1) | 105.651 $ | 0,00 | 90.300 | |
| BLUE MARLIN THERAPEUTICS, INC. | BLUE MARLIN THERAPEUTICS, INC. | EC | Long | Schätzwert (Stufe 3) | beschränkt | 102.250 $ | 0,00 | 1.636 | |
| INHIBIKASE THERAPEUTICS INC | INHIBIKASE THERAPEUTICS INC | EC | 45719W205 | Long | Börsenkurs (Stufe 1) | 98.473 $ | 0,00 | 56.270 | |
| ULTRAGENYX PHARMACEUTICAL INC | ULTRAGENYX PHARMA INC | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 83.527 $ | 0,00 | 3.489 | |
| MYOS CORP | MYOS CORP RESTRICTED | EC | Long | Schätzwert (Stufe 3) | 41.668 $ | 0,00 | 33.334 | ||
| AFFERENT PHARMA | AFFERENT PHARMACEUTICALS INC SER C PC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 83 $ | 0,00 | 8.274.568 | |
| CHINOOK THERAPEUTICS INC | CHINOOK THERAPEUTICS INC CVR RT | EC | Long | Schätzwert (Stufe 3) | 1 $ | 0,00 | 115.821 | ||
| OPTINOSE INC | OPTINOSE INC WT 11/23/27 | EC | 68404V118 | Long | Schätzwert (Stufe 3) | 1 $ | 0,00 | 91.712 | |
| AXCELLA HEALTH INC | AXCELLA HEALTH INC | EC | 05454B204 | Long | Schätzwert (Stufe 3) | 1 $ | 0,00 | 66.454 | |
| MEDAVAIL HOLDINGS INC | MEDAVAIL HOLDINGS INC PIPE | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 55 | |
| 5.260.390.750 $ | 99,89 | 196.001.475 |